Rab10 Thr73

Adding a phosphate group at Thr73 changes how Rab10 interacts with downstream effector proteins. Because these interactions help determine outputs of the Rab GTPase cycle, the modification can alter membrane trafficking processes regulated by Rab10. In biochemical studies, comparing signaling associated with this phosphorylation site helps connect LRRK2 activity with changes in Rab10-dependent pathway regulation.

Thr73 provides a defined position for examining how LRRK2 recognizes and modifies Rab10. Measuring phosphorylation at this residue links kinase activity to a specific substrate site rather than treating pathway activation as an undifferentiated signal. This makes the site useful for characterizing the biochemical relationship between LRRK2 and Rab10 and for investigating how pathway regulation changes.

The phosphorylation state of Thr73 adds a regulatory layer to the Rab GTPase cycle. Rab10 activity is not considered only through its cycling behavior, because LRRK2-dependent modification can alter effector interactions and associated trafficking outputs. Studying this site therefore helps researchers examine how phosphorylation intersects with the cycle to influence downstream membrane-trafficking regulation.

A biochemical assay can use phosphorylation at Thr73 as a defined readout of LRRK2 activity toward Rab10. The resulting measurement supports analysis of kinase activity, substrate recognition, and pathway regulation in a controlled experimental context. Because the readout is tied to a specific modification site, it can help distinguish changes in LRRK2 signaling from broader, nonspecific pathway observations.

Changes in Thr73 phosphorylation can indicate whether a kinase-targeted inhibitor affects LRRK2 signaling toward Rab10. Researchers can use this molecular marker to relate inhibitor treatment to the biochemical activity of the pathway and to assess pathway regulation. This application is especially relevant when studying compounds intended to modify abnormal LRRK2 signaling associated with Parkinson’s disease.

Rab10 Thr73 connects biochemical analysis of LRRK2 with disease-mechanism studies because abnormal LRRK2 signaling is associated with Parkinson’s disease. Measuring this site helps researchers track a defined molecular consequence of that signaling and examine how pathway-targeted inhibitors alter it. The marker therefore supports both mechanistic investigation and evaluation of potential kinase-directed interventions.